CPIX - Cumberland Pharmaceuticals Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

6.51

-0.33 (-4.82%)

At close: 4:00PM EDT

Stock chart is not supported by your current browser

Previous Close	6.90
Open	6.79
Bid	5.00 x 9800
Ask	10.00 x 100
Day's Range	6.48 - 6.87
52 Week Range	5.39 - 7.96
Volume	13,837
Avg. Volume	16,801

Market Cap	101.897M
Beta	0.39
PE Ratio (TTM)	N/A
EPS (TTM)	-0.50
Earnings Date	May 14, 2018 - May 18, 2018
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	5.50

Trade prices are not sourced from all markets

All

News

Press Releases

PR Newswire12 days ago
Cumberland Pharmaceuticals Expands into Oncology Support
NASHVILLE, Tenn., April 9, 2018 /PRNewswire/ -- Cumberland Pharmaceuticals – announced today that it has expanded its medical specialties to include oncology-related medications. "Since the company's founding, Cumberland has endeavored to deliver high quality medicines to improve patient care," said CEO AJ Kazimi. As a result, quality of life becomes of paramount concern – and Cumberland's focus is on supporting cancer patients during their treatment, with the goal of improving their ongoing quality of life.
Simply Wall St.23 days ago
Why Cumberland Pharmaceuticals Inc’s (NASDAQ:CPIX) Ownership Structure Is Important
Today, I will be analyzing Cumberland Pharmaceuticals Inc’s (NASDAQ:CPIX) recent ownership structure, an important but not-so-popular subject among individual investors. Ownership structure has been found to have an impact onRead More...
PR Newswire26 days ago
Newly Published Data Demonstrates 85% Eradication of Ulcer Causing Bacteria
NASHVILLE, Tenn., March 26, 2018 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (CPIX), a U.S. specialty pharmaceutical company announced today the publication of an open access article in Infection and Drug Resistance, with results demonstrating an 85% eradication rate of Helicobacter pylori (H. pylori) infection using clarithromycin-based triple therapy. Cumberland markets a branded clarithromycin-based triple therapy in the U.S. under the name Omeclamox®-Pak. H. pylori has long been known as a common pathogen associated with gastric ulcers and related dyspeptic symptoms in many infected patients.
Thomson Reuters StreetEventslast month
Edited Transcript of CPIX earnings conference call or presentation 6-Mar-18 9:30pm GMT
Q4 2017 Cumberland Pharmaceuticals Inc Earnings Call
Associated Press2 months ago
Cumberland reports 4Q loss
The Nashville, Tennessee-based company said it had a loss of 5 cents per share. Earnings, adjusted for one-time gains and costs, came to 3 cents per share. The pharmaceutical company posted revenue of ...
PR Newswire2 months ago
Cumberland Pharmaceuticals Reports 25% Revenue Growth For The Full Year 2017
- National sales and distribution of Totect® initiated - New Data on Caldolor® and Vaprisol® published - Co-promotion for Kristalose® launched NASHVILLE, Tenn. , March 6, 2018 /PRNewswire/ -- Cumberland ...
ACCESSWIRE2 months ago
Cumberland Pharmaceuticals Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / March 6, 2018 / Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 6, 2018 at 4:30 PM Eastern ...
PR Newswire2 months ago
Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2017 Financial Results
NASHVILLE, Tenn. , Feb. 27, 2018 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release fourth quarter and annual 2017 financial results after the market closes ...
Simply Wall St.2 months ago
Why You Need To Look At This Factor Before Buying Cumberland Pharmaceuticals Inc (NASDAQ:CPIX)
For Cumberland Pharmaceuticals Inc’s (NASDAQ:CPIX) shareholders, and also potential investors in the stock, understanding how the stock’s risk and return characteristics can impact your portfolio is important. Every stock inRead More...
Simply Wall St.2 months ago
Is Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) A Financially Sound Company?
Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) is a small-cap stock with a market capitalization of US$109.29M. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, theyRead More...
PR Newswire3 months ago
Newly Published Data Demonstrates Amifostine Reduces Gastro-Intestinal Toxicity For Multiple Myeloma Patients
Amifostine may prevent gastro-intestinal toxicities in certain cancer patients. NASHVILLE, Tenn. , Jan. 30, 2018 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) , a U.S. specialty pharmaceutical ...
American City Business Journals4 months ago
The fastest-growing Nashville health care company of 2017 might surprise you
Nashville is well known for the collection of health care providers that call Music City home. Cumberland Pharmaceuticals Inc. (CPIX), a specialty pharmaceutical company founded in 1999, has seen its stock price rise more than 33 percent to $7.35, and as high as 44 percent, since the beginning of the year. Community Healthcare Trust Inc.’s stock price has risen second-fastest at almost 22 percent, as of today.
Simply Wall St.4 months ago
Is Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) Excessively Paying Its CEO?
A. Kazimi took the helm as Cumberland Pharmaceuticals Inc’s (NASDAQ:CPIX) CEO and grew market cap to $116.38M recently. Understanding how CEOs are incentivised to run and grow their company isRead More...
Simply Wall St.4 months ago
Who Owns Cumberland Pharmaceuticals Inc (NASDAQ:CPIX)?
In this article, I’m going to take a look at Cumberland Pharmaceuticals Inc’s (NASDAQ:CPIX) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject amongRead More...
Simply Wall St.5 months ago
Cumberland Pharmaceuticals Inc (CPIX): How Much Growth Is Left In Healthcare?
Cumberland Pharmaceuticals Inc (NASDAQ:CPIX), a USD$125.35M small-cap, operates in the healthcare industry, which faces key trends such as rising demand fuelled by an aging population and the growing prevalence ofRead More...
Thomson Reuters StreetEvents5 months ago
Edited Transcript of CPIX earnings conference call or presentation 7-Nov-17 9:30pm GMT
Q3 2017 Cumberland Pharmaceuticals Inc Earnings Call
Capital Cube5 months ago
Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017
Categories: Yahoo FinanceGet free summary analysis Cumberland Pharmaceuticals, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Cumberland Pharmaceuticals, Inc. – Ironwood Pharmaceuticals, Inc. Class A, Pernix Therapeutics Holdings, Inc., DURECT Corporation, Akorn, Inc., Merck & Co., Inc., Mylan N.V., Sucampo Pharmaceuticals, Inc. Class A ... Read more (Read more...)
Associated Press5 months ago
Cumberland reports 3Q loss
On a per-share basis, the Nashville, Tennessee-based company said it had a loss of 5 cents. Earnings, adjusted for non-recurring costs and stock option expense, were 1 cent per share. The pharmaceutical ...
PR Newswire5 months ago
Cumberland Pharmaceutical Reports 27% Revenue Growth In The Third Quarter
- Launched Totect® in the United States - Implemented Kristalose® Co-Promotion Agreement NASHVILLE, Tenn. , Nov. 7, 2017 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) , a specialty pharmaceutical ...
ACCESSWIRE5 months ago
Cumberland Pharmaceuticals Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / November 7, 2017 / Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 7, 2017 at 4:30 ...
PR Newswire6 months ago
Cumberland Pharmaceuticals to Announce Third Quarter 2017 Financial Results
NASHVILLE, Tenn. , Oct. 31, 2017 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release third quarter 2017 financial results after the market closes on Tuesday, ...
Simply Wall St.6 months ago
Should You Be Holding Cumberland Pharmaceuticals Inc (CPIX) Right Now?
If you are a shareholder in Cumberland Pharmaceuticals Inc’s (NASDAQ:CPIX), or are thinking about investing in the company, knowing how it contributes to the risk and reward profile of yourRead More...
Capital Cube6 months ago
ETFs with exposure to Cumberland Pharmaceuticals, Inc. : October 25, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cumberland Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to CPIX-US. Comparing the performance and risk of Cumberland Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)